Avalign Technologies ("Avalign"), a portfolio company of Arlington Capital Partners ("Arlington Capital"), is excited to announce the addition of Thortex (a Portland Oregon based company) to the Avalign family of companies.
Thortex is an industry leading provider of proprietary porous coatings and metal injection molding as well as precision manufacturing solutions to the medical device market. Thortex is one of the only companies in the world able to provide porous coating solutions for titanium and cobalt-chrome orthpedic implants manufactured from castings, forgings and bar stock. In addition, Thortex provides a full suite of manufacturing and engineering technologies including metal injection molding, CNC machining, finishing and assembly to medical device OEMs.
Matt Altman, a Managing Partner at Arlington Capital said, "The incorporation of Thortex into the Avalign platform adds new and proprietary capabilities which enhance Avalign's strategic position in the marketplace. The increased scale and breadth of services and technologies provided by this acquisition will accrue to the benefit of all Avalign's customers.
Forrest Whittaker, CEO of Avalign Technologies comments, "We are excited to welcome Thortex to the Avalign family, and thankful for Arlington's support in consummating this highly strategic acquistion." We believe the combination of Avalign's existing suite of industry leading services with the multiple proprietary technologies developted by Thortex represent a truly unique offering in the market that we are confident will drive significant additional value to both current Avalign and Thortex customer relationships.
Thank you for the business Avalign and Thortex enjoys with your organization today. We highly value the trust you have placed in us and commit to delivering even higher levels of value and pperformance to you and your teams. All customer service and sales representatives from both Avalign and Thortex remain in place and welcome your call with any additional questions.